Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ROAR-A: Re-optimization Based Online Adaptive Radiotherapy of Anal Cancer

NCT05438836 is registered in ClinicalTrials.gov with Herlev Hospital as lead sponsor.

NCT NCT05438836
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05438836 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ROAR-A: Re-optimization Based Online Adaptive Radiotherapy of Anal Cancer
Lead sponsor
Herlev Hospital
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2022
Completion date
January 1, 2031
Enrollment
205 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anal cancer, anal carcinoma, anal squamous cell carcinoma